Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Since its launch, Isomorphic Labs has focused on using AI to model biological processes and accelerate drug discovery. The company co-developed AlphaFold 3 with Google DeepMind, an AI model ...
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results